ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0374

Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic

Merav Heshin Bekenstein1, Rebecca Hetrick2, Vidya Sivaraman3, Beth Rutstein4, Albert Chow5, Peter Chiraseveenuprapund6, Vincent Del Gaizo7, Melanie Kohlheim8, guy Brock9, Sapuni Chandrasena9, Chloé Janse van Rensburg10 and Marina Gad El Sayed11, 1Tel Aviv Medical Center Israel, Binyamina, Tel Aviv, Israel, 2Indiana University School of Medicine, Indianapolis, IN, 3Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 4The Children's Hospital of Philadelphia, Wynnewood, PA, 5Loma Linda University, Loma Linda, CA, 6University of Utah, Salt Lake City, UT, 7Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, NJ, 8CARRA, Granville, OH, 9The Ohio State University Wexner Medical Center, Columbus, OH, 10Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada, 11University of California, Riverside School of Medicine, Riverside, CA

Meeting: ACR Convergence 2025

Keywords: health behaviors, health status, Pediatric rheumatology, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0357–0386) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Vaccine-preventable diseases pose greater risk to children with rheumatic diseases treated with immunosuppressive therapies and to those with underlying immune dysregulation. Despite the importance of vaccine protection, children with rheumatic disease often have lower vaccination rates compared to healthy populations. The drivers of decreased vaccine uptake in pediatric rheumatic disease (PRD) are poorly understood. This study examines the caregiver attitudes and barriers surrounding immunization in PRD patients.

Methods: This study included a voluntary online survey of caregivers of PRD patients recruited through online parent support groups for PRD patients from June – July 2024. General vaccine hesitancy was assessed via a modified Parental Attitudes about Childhood Vaccines – Short Form (PACV-SF), a 4-question scale designed to screen for vaccine hesitant caregivers.1 Additional questions on barriers to vaccination were developed by the CARRA Vaccination Work Group. The primary outcome was caregiver report of immunization status. Associations with explanatory variables were assessed using chi-squared tests and Fisher’s exact test for categorical variables and Wilcoxon rank-sum tests for continuous variables. Univariable and multivariable logistic regression analyses were used to examine the association between vaccination status and explanatory variables. Multivariable Model 1 includes all explanatory variables while multivariable Model 2 includes only those found to be significant in the univariable analysis.

Results: Of the 163 respondents, 104 (64%) reported that their child had received all recommended immunizations and 59 (36%) reported partial immunization, no immunization, or uncertain immunization status (Table 1). General vaccine hesitancy, as indicated by a score >2 on the PACV-SF (Figure 1), was strongly associated with a lower odds of immunization uptake (OR 0.16, 95% CI 0.08-0.32, p< 0.001) in all models (Figure 2). Age was associated with increased odds of immunization uptake in the univariable model and multivariable Model 1. Vaccine hesitancy related to rheumatic disease was associated with decreased odds of immunization uptake in the univariable model but this association became non-significant in the multivariable models.

Conclusion: General vaccine hesitancy in caregivers strongly predicted decreased odds of fully immunized status in children. While not surprising, this was the only factor undiminished in all multivariable models, suggesting a strong independent relationship. In contrast, vaccine hesitancy related to the child’s rheumatic disease diagnosis was not significant in the multivariable models. The study’s limitations include unknown generalizability due to convenience sampling and relatively small sample size. Nevertheless, this study suggests that general vaccine hesitancy may play a stronger role in caregiver immunization decisions than other types of barriers.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: M. Heshin Bekenstein: None; R. Hetrick: None; V. Sivaraman: None; B. Rutstein: None; A. Chow: None; P. Chiraseveenuprapund: None; V. Del Gaizo: None; M. Kohlheim: None; g. Brock: None; S. Chandrasena: None; C. van Rensburg: None; M. Gad El Sayed: None.

To cite this abstract in AMA style:

Heshin Bekenstein M, Hetrick R, Sivaraman V, Rutstein B, Chow A, Chiraseveenuprapund P, Del Gaizo V, Kohlheim M, Brock g, Chandrasena S, van Rensburg C, Gad El Sayed M. Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/assessing-attitudes-and-barriers-to-vaccination-in-pediatric-rheumatic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-attitudes-and-barriers-to-vaccination-in-pediatric-rheumatic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology